FDA Approved: HADLIMA — Original Application (Organon LLC)

View source ↗

Summary

FDA approves Hadlima (adalimumab-bwwd) from Organon as a biosimilar to Humira under the original application BLA761059. It is indicated for the same diseases as…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Axial Spondyloarthritis
• Crohn Disease
• Juvenile Idiopathic Arthritis
• Plaque Psoriasis
• Psoriatic Arthritis
• Rheumatoid Arthritis
• Ulcerative Colitis

Drugs mentioned

• HADLIMA (ADALIMUMAB-BWWD)

Snippet

ORIG AP for HADLIMA (ADALIMUMAB-BWWD)